Analyst Upgrades

• Aetna (AET) to buy from neutral at Goldman.
• Kellogg (K) to buy from neutral at UBS.
• PetSmart (PETM) to outperform from market perform at JMP Securities.
• NetApp (NTAP) and Scripps Networks (SNI) to buy from hold at Wunderlich.
• Thoratec (THOR) to buy from hold at Auriga.
• ArcelorMittal (MT) to overweight from neutral at HSBC.
• Bristol-Myers (BMY) to outperform from neutral at Cowen.
• Eaton Vance (EV) to neutral from sell at Ticonderoga.
• Adtran (ADTN) to buy from underperform at BofA/Merrill.

Continue reading Analyst Calls: AET, BMY, DVN, GLW, K, MRK, MT, PETM, SPLS, WY ...

Analyst Calls: AET, BMY, DVN, GLW, K, MRK, MT, PETM, SPLS, WY ... originally appeared on BloggingStocks on Mon, 07 Feb 2011 11:40:00 EST. Please see our terms for use of feeds.

Analyst Calls

• Medtronic (MDT) to buy from neutral and 1-800-Flowers.com (FLWS) to neutral from sell at Goldman.
• CarMax (KMX) to outperform from perform at Oppenheimer.
• Points International (PTSEF) to buy from neutral at Merriman.
• Nokia (NOK) to market perform from underperform at Morgan Keegan.
• Amdocs (DOX) to overweight from equal weight at Barclays.
• Western Alliance (WAL) to outperform from sector perform at RBC Capital.
• Carbo Ceramics (CRR) to outperform from market perform at BMO Capital.
• Rackspace (RAX) to buy from hold at Benchmark Co.
• Brinker (EAT) to equal weight from underweight at Morgan Stanley.

Continue reading Analyst Calls: BP, EAT, JBLU, KMX, MDT, MYGN, NOK, NTRS, RAX, RDS.A, T ...

Analyst Calls: BP, EAT, JBLU, KMX, MDT, MYGN, NOK, NTRS, RAX, RDS.A, T ... originally appeared on BloggingStocks on Fri, 28 Jan 2011 11:20:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Thoratec (THOR) to buy from neutral at UBS.
• TW Telecom (TWTC) to buy from hold at Citigroup.
• TAL Education (XRS) to overweight from neutral at Piper Jaffray.
• Amedisys (AMED) to buy from hold at Deutsche Bank.

Analyst Downgrades

• Navigators (NAVG) to neutral from outperform at Macquarie.
• El Paso Electric (EE) to hold from buy at Jefferies.
• Hancock Holding (HBHC) to hold from buy at Wunderlich.
• California Water Service (CWT) and American States Water (AWR) to neutral from buy at Janney Capital.
• Mednax (MD) to hold from buy at Deutsche Bank.

Continue reading Analyst Calls: AMED, AMZN, CVC, DOLE, EL, EBAY, NWL, SBUX, THOR, UIS ...

Analyst Calls: AMED, AMZN, CVC, DOLE, EL, EBAY, NWL, SBUX, THOR, UIS ... originally appeared on BloggingStocks on Tue, 21 Dec 2010 11:20:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• DuPont (DD) was upgraded to buy from neutral at Goldman.
• UBS upgraded Deere (DE) to buy from neutral and AGCO (AGCO) to neutral from sell.
• Canadian Solar (CSIQ) was upgraded to outperform from neutral at Macquarie.
• Thoratec (THOR) and DTE Energy (DTE) were upgraded to overweight from equal weight at Barclays.
• NICE Systems (NICE) was upgraded to overweight from neutral at HSBC.
• Deutsche Bank upgraded Copa Holdings (CPA) to buy from hold.
• BofA/Merrill upgraded Nu Skin (NUS) to buy from neutral.
• Continental Resources (CLR) was upgraded to buy from hold at Jefferies.

Continue reading Analyst Calls: CLR, CSIQ, DD, DE, DECK, EMC, EMN, WFMI, WWW ...

Analyst Calls: CLR, CSIQ, DD, DE, DECK, EMC, EMN, WFMI, WWW ... originally appeared on BloggingStocks on Fri, 19 Nov 2010 12:00:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Intel (INTC) was upgraded to overweight from equal weight and Autodesk (ADSK) to equal weight from underweight at Morgan Stanley.
• Citigroup upgraded Blackrock (BLK) to buy from hold.
• 99c Only Stores (NDN) was upgraded to buy from hold at Deutsche Bank.
• PetSmart (PETM) was upgraded to overweight from equal weight at Barclays.
• Piper Jaffray upgraded Ruth's Hospitality (RUTH) and Morton's Restaurant (MRT) to overweight from neutral.
• BioMed Realty (BMR) was upgraded to market perform from underperform at FBR Capital.
• Wells Fargo upgraded Piedmont (PDM) to market perform from underperform.

Continue reading Analyst Calls: AA, AOL, BLK, CSCO, GOOG, INTC, JBL, JBLU, YHOO ...

Analyst Calls: AA, AOL, BLK, CSCO, GOOG, INTC, JBL, JBLU, YHOO ... originally appeared on BloggingStocks on Thu, 11 Nov 2010 12:00:00 EST. Please see our terms for use of feeds.

Thoratec (NASDAQ: THOR), known for its ventricular assist devices (VADs) for patients suffering late-stage heart failure, recently bought Australia's HeartWare. Investors responded positively to this move because it brings new technology to Thoratec and expands the company's already significant market share.

THOR currently has 85% of the U.S. heart pump market and 65% of Europe's, and this new technology could ensure THOR stays on the top of this market for at least the next five to 10 years. The Thoratec-HeartWare partnership has the potential to grow into a multibillion-dollar business, which will translate to big sales and earnings growth.

Continue reading Small-cap stock #5: Thoratec (THOR)

Small-cap stock #5: Thoratec (THOR) originally appeared on BloggingStocks on Sun, 17 May 2009 14:00:00 EST. Please see our terms for use of feeds.

Small-cap stocks are a GREAT place to start if you're serious about rebuilding your wealth and securing your financial future.

But what makes small-cap stocks so spectacular?

The bear market stripped analysts from small stocks -- hardly anyone is covering them anymore. This creates wonderful pricing anomalies and gives the individual investor a significant edge.

Continue reading 5 small-cap stocks to buy now

5 small-cap stocks to buy now originally appeared on BloggingStocks on Sat, 16 May 2009 09:00:00 EST. Please see our terms for use of feeds.

In The Oberweis Report, growth expert Jim Oberweis. Jr. sees upside for risk-oriented investors in two diagnostics firms: Myriad Genetics (NASDAQ: MYGN) and Thoratec (NASDAQ: THOR).

"Myriad develops molecular diagnostic products focused in the area of predictive caner diagnostics. It currently sells five genetic tests (and just recently announced the launch of a 6th test in December) focused on cancer and women's health.

"The bulk of their revenues currently come from their BRACAnalysis test for breast cancer. This test is the only one of its kind available to detect a faulty version of BRAC genes in women, which has been linked to significantly increased chances of developing breast and ovarian cancers.

Continue reading Diagnostics duo: Myriad (MYGN) and Thoratec (THOR)

Diagnostics duo: Myriad (MYGN) and Thoratec (THOR) originally appeared on BloggingStocks on Tue, 17 Mar 2009 10:30:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Keefe Bruyette resumed coverage of Old Republic (NYSE:ORI), MGIC Investment (NYSE:MTG), PMI Group (NYSE:PMI) and Radian (NYSE:RDN) with Market Perform ratings and a $16 target, $13 target, $7 target and $6.50 target, respectively, as they expect increased capital needs to generate operational headwinds in the near-term.
  
• JMP Securities expects FDA approval of Thoratec's (NASDAQ:THOR) next generation HeartMate II VAD any day now and for the company to meet/beat 2008 sales guidance. Shares were started with an Outperform rating and $20 target.
  
• Callaway Golf (NYSE:ELY) was assumed at Stephens with an Overweight rating and $19 target. The firm is positive on Callaway's leadership position, strong balance sheet, new products and international opportunity.

• Kaufman Bros. initiated Bancscares of Florida (NASDAQ:BOFL) with a Buy rating and $15.50 target.
  
• Raymond James started Dialysis Corp of America (NASDAQ:DCAI) with a Strong Buy rating and $9 target.
  
• Intuitive Surgical (NASDAQ:ISRG) was initiated at Lazard with a Buy rating and $420 target.

Analyst initiations: Mortgage insurers, THOR and ELY originally appeared on BloggingStocks on Thu, 10 Apr 2008 11:25:00 EST. Please see our terms for use of feeds.